Matthias Hünger

2.0k total citations
73 papers, 1.4k citations indexed

About

Matthias Hünger is a scholar working on Oncology, Economics and Econometrics and Epidemiology. According to data from OpenAlex, Matthias Hünger has authored 73 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 17 papers in Economics and Econometrics and 14 papers in Epidemiology. Recurrent topics in Matthias Hünger's work include Health Systems, Economic Evaluations, Quality of Life (15 papers), Polyomavirus and related diseases (9 papers) and Chronic Disease Management Strategies (8 papers). Matthias Hünger is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (15 papers), Polyomavirus and related diseases (9 papers) and Chronic Disease Management Strategies (8 papers). Matthias Hünger collaborates with scholars based in Germany, United States and United Kingdom. Matthias Hünger's co-authors include Rolf Holle, Annette Peters, Christa Meisinger, Angela Döring, Margit Heier, Larissa Schwarzkopf, Michaela Schunk, Reiner Leidl, Björn Stollenwerk and Andreas Mielck and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Matthias Hünger

70 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Matthias Hünger Germany	19	352	323	296	167	166	73	1.4k
Priscilla Velentgas United States	18	318 0.9×	268 0.8×	188 0.6×	219 1.3×	275 1.7×	42	1.8k
Sarah M. McGhee Hong Kong	28	347 1.0×	328 1.0×	368 1.2×	189 1.1×	147 0.9×	75	1.7k
Mike Crilly United Kingdom	16	326 0.9×	445 1.4×	264 0.9×	221 1.3×	107 0.6×	46	1.5k
Wanrudee Isaranuwatchai Canada	23	327 0.9×	279 0.9×	380 1.3×	163 1.0×	204 1.2×	152	1.9k
Robert J. Stroebel United States	19	692 2.0×	315 1.0×	281 0.9×	285 1.7×	173 1.0×	56	1.5k
Enno Nowossadeck Germany	19	493 1.4×	201 0.6×	182 0.6×	157 0.9×	81 0.5×	58	1.1k
Arturo González-Izquierdo United Kingdom	20	346 1.0×	257 0.8×	99 0.3×	261 1.6×	206 1.2×	62	1.9k
Ming‐Chin Yang Taiwan	22	313 0.9×	224 0.7×	261 0.9×	123 0.7×	111 0.7×	106	1.4k
Dominik Ose Germany	23	626 1.8×	401 1.2×	269 0.9×	386 2.3×	185 1.1×	103	1.5k
Ali Kiadaliri Sweden	21	290 0.8×	201 0.6×	259 0.9×	132 0.8×	75 0.5×	115	1.5k

Countries citing papers authored by Matthias Hünger

Since Specialization

Citations

This map shows the geographic impact of Matthias Hünger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthias Hünger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthias Hünger more than expected).

Fields of papers citing papers by Matthias Hünger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthias Hünger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthias Hünger. The network helps show where Matthias Hünger may publish in the future.

Co-authorship network of co-authors of Matthias Hünger

This figure shows the co-authorship network connecting the top 25 collaborators of Matthias Hünger. A scholar is included among the top collaborators of Matthias Hünger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthias Hünger. Matthias Hünger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kimball, Samantha, et al.. (2024). Vaccine preparation time, errors, satisfaction, and preference of prefilled syringes versus RSV vaccines requiring reconstitution: randomized, time and motion study. Journal of Medical Economics. 27(1). 887–896. 3 indexed citations

Shen, Qin, et al.. (2023). Outcomes for Dostarlimab and Real-World Treatments in Post-platinum Patients With Advanced/Recurrent Endometrial Cancer: The GARNET Trial Versus a US Electronic Health Record-Based External Control Arm. Journal of health economics and outcomes research. 53–61. 3 indexed citations

Knott, Craig, et al.. (2023). Outcomes of dostarlimab versus chemotherapy in post-platinum patients with recurrent/advanced endometrial cancer: data from the GARNET trial and the National Cancer Registration Service in England. International Journal of Gynecological Cancer. 33(11). 1715–1723. 2 indexed citations

Spada, Cristiano, Anastasios Koulaouzidis, Cesare Hassan, et al.. (2022). Factors Associated with Withdrawal Time in European Colonoscopy Practice: Findings of the European Colonoscopy Quality Investigation (ECQI) Group. Diagnostics. 12(2). 503–503. 3 indexed citations

Spada, Cristiano, Anastasios Koulaouzidis, Cesare Hassan, et al.. (2022). Factors Associated with Polyp Detection Rate in European Colonoscopy Practice: Findings of The European Colonoscopy Quality Investigation (ECQI) Group. International Journal of Environmental Research and Public Health. 19(6). 3388–3388. 4 indexed citations

Hünger, Matthias, et al.. (2020). Mapping the Kansas City Cardiomyopathy Questionnaire (KCCQ) Onto EQ-5D-3L in Heart Failure Patients: Results for the Japanese and UK Value Sets. MDM Policy & Practice. 5(2). 3444620118–3444620118. 3 indexed citations

Bharmal, Murtuza, Matthias Hünger, & Michael Schlichting. (2019). Psychometric Properties of EQ-5D-5L Scoring Algorithms for the United Kingdom in Metastatic Merkel Cell Carcinoma. Value in Health. 22(10). 1170–1177. 2 indexed citations

Eriksson, Jennifer, et al.. (2019). Cost and utility in immunocompromised subjects who developed herpes zoster during the randomized V212 inactivated varicella-zoster vaccine (ZV_IN) trial. Expert Review of Pharmacoeconomics & Outcomes Research. 20(6). 613–621. 1 indexed citations

D’Angelo, Sandra P., Matthias Hünger, Andrew S. Brohl, et al.. (2019). Early objective response to avelumab treatment is associated with improved overall survival in patients with metastatic Merkel cell carcinoma. Cancer Immunology Immunotherapy. 68(4). 609–618. 17 indexed citations

10.

Zanotti, Giovanni, et al.. (2017). Treatment patterns and real world clinical outcomes in ER+/HER2- post-menopausal metastatic breast cancer patients in the United States. BMC Cancer. 17(1). 393–393. 17 indexed citations

11.

Maksymowych, Walter P., Vibeke Strand, Peter Nash, et al.. (2016). Secukinumab for the treatment of ankylosing spondylitis: comparative effectiveness results versus adalimumab Using a matching-adjusted indirect comparison. Clinical and Experimental Rheumatology. 34(4). 782–782. 4 indexed citations

12.

Boxall, Naomi, Dimitri Bennett, Matthias Hünger, Paul Dolin, & Paula Louise Thompson. (2016). Evaluation of exposure to pioglitazone and risk of prostate cancer: a nested case–control study. BMJ Open Diabetes Research & Care. 4(1). e000303–e000303. 8 indexed citations

13.

Teuner, Christina M., Matthias Hünger, Rolf Holle, et al.. (2016). The Economic Burden of Obesity in Germany: Results from the Population-Based KORA Studies. Obesity Facts. 9(6). 397–409. 25 indexed citations

14.

Laxy, Michael, Matthias Hünger, Barbara Thorand, et al.. (2014). The Intermediate Burden Of Diabetes Mellitus In Patients With Cardiovascular Disease (Cvd): A Quality Adjusted Life Year (Qaly) -Analysis Based On Primary Longitudinal Data. Value in Health. 17(7). A494–A494. 3 indexed citations

15.

Wacker, Margarethe, Matthias Hünger, Holger Schulz, et al.. (2014). Health economics of COPD: First results of the new German COSYCONET cohort compared to population-based controls from KORA. European Respiratory Journal. 44(Suppl 58). 4440–4440.

16.

Seidl, Hildegard, Rolf Holle, Bernhard Kuch, et al.. (2014). New potential determinants of disability in aged persons with myocardial infarction: results from the KORINNA-study. BMC Geriatrics. 14(1). 34–34. 13 indexed citations

17.

Hünger, Matthias, et al.. (2014). Nimmt die gesundheitliche Ungleichheit zu?. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz. 57(4). 431–444. 1 indexed citations

18.

Stark, Renée, Inge Kirchberger, Matthias Hünger, et al.. (2013). Improving care of post-infarct patients: effects of disease management programmes and care according to international guidelines. Clinical Research in Cardiology. 103(3). 237–245. 16 indexed citations

19.

Maier, Werner, Rolf Holle, Matthias Hünger, et al.. (2012). The impact of regional deprivation and individual socio‐economic status on the prevalence of Type 2 diabetes in Germany. A pooled analysis of five population‐based studies. Diabetic Medicine. 30(3). e78–86. 111 indexed citations

20.

Hünger, Matthias, Barbara Thorand, Michaela Schunk, et al.. (2011). Multimorbidity and health-related quality of life in the older population: results from the German KORA-Age study. Health and Quality of Life Outcomes. 9(1). 53–53. 129 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact